Evidence map›Paper›PMID 16606853›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11).

Annie P Chiang, John S Beck, Hsan-Jan Yen, Marwan K Tayeh, Todd E Scheetz, Ruth E Swiderski, Darryl Y Nishimura, Terry A Braun, Kwang-Youn A Kim, Jian Huang and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 168 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
168citing papers in PubMed, 1 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

168 citing papers in PubMed, 1 synthesis or guideline pooled it, 426 citations in OpenAlex.

  1. Pooled it
  2. Ciliary Defects in Inherited Retinal Diseases.Advanced genetics (Hoboken, N.J.) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Model-Free Statistical Inference on High-Dimensional Data.Journal of the American Statistical Association · 2025
    Article
  9. Review
  10. TheActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Kinase Inhibitors in Genetic Diseases.International journal of molecular sciences · 2023
    Review
  20. Article

108 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Annie P ChiangDepartment of Electrical Engineering, University of Iowa, Iowa City, IA 52242, USA.
John S Beck
Hsan-Jan Yen
Marwan K Tayeh
Todd E Scheetz
Ruth E Swiderski
Darryl Y Nishimura
Terry A Braun
Kwang-Youn A Kim
Jian Huang
Khalil Elbedour
Rivka Carmi
Diane C Slusarski
Thomas L Casavant
Edwin M Stone
Val C Sheffield
Pediatrics and Genetics · USHoward Hughes Medical Institute · USOphthalmology Associates (United States) · USUniversity of Iowa · USBen-Gurion University of the Negev · ILInstitute of Biophysics and Biomedical Engineering · BGSoroka Medical Center · ILStatistical Service · CY

Funding

Sympathetic and vascular control in genetic obesityP50HL055006 · NHLBI · UNIVERSITY OF IOWA · PI SHEFFIELD, VAL C · 1996 to 2005
$12.5M
Treatment of a Complex Retinal Degenerative SyndromeR01EY011298 · NEI · UNIVERSITY OF IOWA · PI SHEFFIELD, VAL C. · 1996 to 2017
$7.3M
NEI NIH HHS R01 EY011298NEI NIH HHS R01-EY-11298NHLBI NIH HHS P50 HL055006NHLBI NIH HHS P50-HL-55006
6 · The paper itself

Abstract

The identification of mutations in genes that cause human diseases has largely been accomplished through the use of positional cloning, which relies on linkage mapping. In studies of rare diseases, the resolution of linkage mapping is limited by the number of available meioses and informative marker density. One recent advance is the development of high-density SNP microarrays for genotyping. The SNP arrays overcome low marker informativity by using a large number of markers to achieve greater coverage at finer resolution. We used SNP microarray genotyping for homozygosity mapping in a small consanguineous Israeli Bedouin family with autosomal recessive Bardet-Biedl syndrome (BBS; obesity, pigmentary retinopathy, polydactyly, hypogonadism, renal and cardiac abnormalities, and cognitive impairment) in which previous linkage studies using short tandem repeat polymorphisms failed to identify a disease locus. SNP genotyping revealed a homozygous candidate region. Mutation analysis in the region of homozygosity identified a conserved homozygous missense mutation in the TRIM32 gene, a gene coding for an E3 ubiquitin ligase. Functional analysis of this gene in zebrafish and expression correlation analyses among other BBS genes in an expression quantitative trait loci data set demonstrate that TRIM32 is a BBS gene. This study shows the value of high-density SNP genotyping for homozygosity mapping and the use of expression correlation data for evaluation of candidate genes and identifies the proteasome degradation pathway as a pathway involved in BBS.

Indexed as

Polymorphism, Single NucleotideAnimalsBardet-Biedl SyndromeChromosome MappingDNA Mutational AnalysisGenome, HumanHomozygoteHumansMutationOligonucleotide Array Sequence AnalysisTranscription FactorsTripartite Motif ProteinsUbiquitin-Protein LigasesZebrafishZebrafish ProteinsTranscription FactorsTRIM32 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesZebrafish Proteins

Identifiers

PMID16606853
PMCPMC1458870
OpenAlexW2114810168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.